CBDX 0.00 Curative Biosciences, Inc.
| Range: | 1.0E-4-0.0015 | Vol Avg: | 2 | Last Div: | 0 | Changes: | 0 |
| Beta: | 7.86 | Cap: | 0.00B | Currency: | USD | Exchange: | PNK |
| Sector: | Healthcare | IPO: | Thu Aug 26 2004 | Empoloyees: | |||
| CUSIP: | CIK: | ISIN: | US23127M1018 | Country: | US | ||
| CEO: | Mr. Richard Damion | Website: | https://curativebio.com | ||||
Curative Biosciences, Inc. focuses on developing and commercializing therapeutics using hemp-derived Cannabidiol. It intends to manufacture and market natural health products and operate in the medical cannabis industry. The company was formerly known as Amaize Beverage Corporation and changed its name to Curative Biosciences, Inc. in August 2017. Curative Biosciences, Inc. was founded in 2009 and is based in Miami, Florida.
Stock Details
About The Monevue
The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.
• Powered by StackThrow